B. P. Setchell, The testis and tissue transplantation: historical aspects, J Reprod Immunol, vol.18, pp.1-8, 1990.

M. Fijak, S. Bhushan, and A. Meinhardt, Immunoprivileged sites: the testis, Methods Mol. Biol, vol.67, pp.459-470, 2011.

C. V. Pérez, Dual role of immune cells in the testis: Protective or pathogenic for germ cells, Spermatogenesis, vol.3, issue.1, 2013.

K. S. Tung, Egress of sperm autoantigen from seminiferous tubules maintains systemic tolerance, The Journal of Clinical Investigation, vol.123, issue.3, pp.1046-1060, 2017.

P. De-cesaris, Immunosuppressive molecules produced by Sertoli cells cultured in vitro: biological effects on lymphocytes, Biochem. Biophys. Res. Commun, vol.186, pp.1639-1646, 1992.

C. R. Wyatt, L. Law, J. A. Magnuson, M. D. Griswold, and N. S. Magnusoru, Suppression of lymphocyte proliferation by proteins secreted by cultured Sertoli cells, J. Reprod. Immunol, vol.14, pp.27-40, 1988.

P. R. Sanberg, C. V. Borlongan, S. Saporta, and D. F. Cameron, Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain, Nature Biotechnology, vol.14, pp.1692-1695, 1996.

W. Suarez-pinzon, Testicular Sertoli cells protect islet cells from autoimmune destruction in NOD mice by a Transforming Growth Factor-1-Dependent Mechanism, Diabetes, vol.49, pp.810-1818, 2000.

F. Fallarino, Therapy of experimental type 1 diabetes by isolated Sertoli cells xenografts alone, J. Exp. Med, vol.206, pp.2511-2526, 2009.

F. Forouhar, Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase, Proc. Natl. Acad. Sci, vol.104, pp.473-478, 2007.

R. Metz, Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound d-1-methyl-tryptophan, Cancer Res, vol.67, pp.7082-7087, 2007.

U. Grohmann, F. Fallarino, P. Puccetti, and . Tolerance, DCs and tryptophan: much ado about IDO, Trends Immunol, vol.24, pp.242-248, 2003.

A. L. Mellor and D. H. Munn, IDO expression by dendritic cells: tolerance and tryptophan catabolism, Nat. Rev. Immunol, vol.4, pp.762-774, 2004.

L. Romani, Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease, Nature, vol.451, pp.211-215, 2008.

F. Fallarino, The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells, J. Immunol, vol.176, issue.11, pp.6752-6761, 2006.

P. Puccetti and U. Grohmann, IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation, Nat. Rev. Immunol, vol.7, issue.10, pp.817-823, 2007.

P. Puccetti and F. Fallarino, Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism, Blood Cells Mol. Dis, vol.40, issue.1, pp.101-105, 2008.

D. H. Munn, Prevention of allogeneic fetal rejection by tryptophan catabolism, Science, vol.281, issue.5380, pp.1191-1193, 1998.

U. Grohmann, CTLA-4-Ig regulates tryptophan catabolism in vivo, Nat. Immunol, vol.3, issue.11, pp.1097-1101, 2002.

C. Guillonneau, CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase, J. Clin. Invest, vol.117, issue.4, pp.1096-1106, 2007.

G. J. Gurtner, R. D. Newberry, S. R. Schloemann, K. G. Mcdonald, and W. F. Stenson, Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice, Gastroenterology, vol.125, issue.6, pp.1762-1773, 2003.

S. K. Seo, 4-1BB-mediated immunotherapy of rheumatoid arthritis, Nat. Med, vol.10, issue.10, pp.1088-1094, 2004.

A. Popov, Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection, J. Clin. Invest, vol.116, issue.12, pp.3160-3170, 2006.

U. Grohmann, Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy, Nat. Med, vol.13, issue.5, pp.579-586, 2007.

T. Hayashi, Inhibition of experimental asthma by indoleamine 2,3-dioxygenase, J. Clin. Invest, vol.114, issue.2, pp.270-279, 2004.

G. F. Doncel, J. A. Di-paola, and L. Lustig, Sequential study of the histopathology and cellular and humoral immune response during the development of an autoimmune orchitis in Wistar rats, Am. J. Reprod. Immunol, vol.20, pp.44-51, 1989.

C. Rival, Functional and phenotypic characteristics of testicular macrophages in experimental autoimmune orchitis, The Journal of Pathology, vol.215, issue.2, pp.108-117, 2008.

K. Wheeler, Regulatory T cells control tolerogenic versus autoimmune response to sperm in vasectomy, Proc. Natl. Acad. Sci. USA, vol.108, pp.7511-7516, 2011.

M. Hill, Heme oxygenase-1 inhibits rat and human breast cancer cells proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase, FASEB J, vol.19, pp.1957-1968, 2005.

M. W. Pfaffl, A new mathematical model for relative quantification in real-time RT-PCR Nucleic, Acid. Res, vol.29, p.45, 2001.

S. P. Rossi, New insights into melatonin/CRH signaling in hamster Leydig cells, Gen Comp Endocrinol, vol.178, issue.1, pp.153-163, 2012.

C. V. Pérez, Dual roles of endogenous and exogenous galectin-1 in the control of testicular immunopathology, Sci. Rep, vol.5, p.12259, 2015.

D. Y. Hou and J. Muller, Inhibition of IDO in dendritic cells by stereoisomers of 1-M tryptophan correlates with antitumor responses, Cancer Res, vol.67, pp.792-801, 2007.

V. A. Guazzone, Micro-encapsulated secretory leukocyte protease inhibitor decreases cell-mediated immune response in autoimmune orchitis, Life Sciences, vol.89, pp.100-106, 2011.

A. Britan, V. Maffre, S. Tone, and J. R. Drevet, Quantitative and spatial differences in the expression of tryptophan-metabolizing enzymes in mouse epididymis, Cell Tissue Res, vol.324, pp.301-310, 2006.

H. J. Ball, Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice, Gene, vol.396, issue.1, pp.203-213, 2007.

X. Dai and B. T. Zhu, Indoleamine 2,3-Dioxygenase Tissue Distribution and Cellular Localization in Mice: Implications for Its Biological Functions, Journal of Histochemistry & Cytochemistry, vol.58, issue.1, pp.17-28, 2010.

M. A. Jenabian, Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults, AIDS, vol.30, pp.2777-2786, 2016.

C. Lippens, IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity, J. Autoimmun, vol.75, pp.39-49, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01438478

A. Hosseini-tabatabaei, Mechanism Underlying Defective Interferon Gamma-Induced IDO Expression in Non-obese Diabetic Mouse Fibroblasts, PLoS One, vol.7, issue.5, 2012.

P. Mital, G. Kaur, and J. M. Dufour, Immunoprotective Sertoli cells: making allogeneic and xenogeneic trasplatantion feasible, Reproduction, vol.139, pp.495-504, 2010.

A. L. Mellor, H. Lemos, and L. Huang, Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now? Front, 2017.

P. Jacobo, C. V. Pérez, M. S. Theas, V. A. Guazzone, and L. Lustig, CD4+ and CD8+ T cells producing Th1 and Th17 cytokines are involved in the pathogenesis of autoimmune orchitis, Reproduction, vol.141, pp.249-258, 2011.

D. Alberati-giani, Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells, J. Immunol, vol.159, pp.419-426, 1997.

S. Jarazo-dietrich, Up regulation of nitric oxide synthase-nitric oxide system in the testis of rats undergoing autoimmune orchitis, Immunobiology, vol.217, pp.778-787, 2012.

S. Jarazo-dietrich, Inhibition of NOS-NO System Prevents Autoimmune Orchitis Development in Rats: Relevance of NO Released by Testicular Macrophages in Germ Cell Apoptosis and Testosterone Secretion, PLoS One, vol.10, issue.6, p.128709, 2015.

M. Hill, R. Zagani, C. Voisine, C. Usal, and I. Anegon, Nitric oxide and indoleamine 2,3-dioxygenase mediate CTLA4Ig-induced survival in heart allografts in rats, Transplantation, vol.84, issue.8, pp.1060-1063, 2007.

G. Criado, E. Simelyte, J. J. Inglis, D. Essex, and R. O. Williams, Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis, Arthritis Rheum, vol.60, issue.5, pp.1342-1351, 2009.

G. Mondanelli, The Proteasome inhibitor Bortezomib controls indoleamine 2,3-Dioxygenase 1 Breakdown and restores immune regulation in autoimmune, Diabetes. Frontiers in Immunol, vol.8, p.428, 2017.

C. Rival, M. S. Theas, V. A. Guazzone, and L. Lustig, Interleukin-6 and IL-6 receptor cell expression in testis of rats with autoimmune orchitis, J Reprod. Immunol, vol.70, pp.43-58, 2006.

C. V. Pérez, Loss of Occludin Expression and Impairment of Blood-Testis Barrier Permeability in rats with Autoimmune Orchitis: Effect of Interleukin 6 on Sertoli Cell Tight Junctions, Biol Reprod, vol.87, issue.122, pp.1-12, 2012.

F. F. Jusof, Investigation of the Tissue Distribution and Physiological Roles of Indoleamine 2,3-Dioxygenase-2, International. Journal of Tryptophan Research, vol.10, pp.1-12, 2017.

A. Jrad-lamine, Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic state, J. Biol. Chem, vol.286, issue.10, pp.8030-8042, 2011.

K. Sakurai, J. P. Zou, J. R. Tschetter, J. M. Ward, and G. M. Shearer, Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis, Journal of Neuroimmunology, vol.129, pp.186-196, 2002.

E. Kwidzinski, Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation, Faseb J, vol.19, issue.10, pp.1347-1349, 2005.

A. A. Badawy, A. M. Namboodiri, and J. R. Moffett, The end of the road for the tryptophan depletion concept in pregnancy and infection, Clin. Sci. (Lond), vol.130, issue.15, pp.1327-1333, 2016.